These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 7184364

  • 1. [Intralymphatic administration of BCG-CWS in advanced malignant melanoma].
    Mannami T, Matsumi A, Ichikawa J, Kagawa S, Orita K, Motoi M.
    Gan To Kagaku Ryoho; 1982 Jan; 9(1):85-90. PubMed ID: 7184364
    [Abstract] [Full Text] [Related]

  • 2. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
    Yamamura Y, Yoshizaki K, Azuma I, Yagura T, Watanabe T.
    Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
    [Abstract] [Full Text] [Related]

  • 3. [Cellular changes in malignant pleural effusion induced by intrapleural injection of BCG-CWS].
    Matsuda M, Morishita T, Horai T, Ikegami H, Nakamura S, Nishio H.
    Gan No Rinsho; 1983 Aug; 29(9):955-61. PubMed ID: 6620573
    [Abstract] [Full Text] [Related]

  • 4. [Immunological aspects in the treatment of malignant melanoma].
    Cascinelli N, Vaglini M, Rovini D, Orefice S, Marolda R, Veronesi U.
    Minerva Med; 1982 Apr 28; 73(18):1233-40. PubMed ID: 7078802
    [No Abstract] [Full Text] [Related]

  • 5. Effect of BCG cell-wall skeleton on metastasis of syngeneic tumor in rats, with special reference to lymphocyte trapping.
    Ogura T, Namba M, Hirao F, Yamawaki M, Azuma I, Yamamura Y.
    Gan; 1978 Jun 28; 69(3):311-5. PubMed ID: 352783
    [Abstract] [Full Text] [Related]

  • 6. Endolymphatic BCG therapy in the rabbit VX2 tumor.
    Edwards JM, O'Donnell TF, Johnson H, Rutt D, Kinmonth JB.
    Surg Forum; 1975 Jun 28; 26():147-9. PubMed ID: 1216093
    [No Abstract] [Full Text] [Related]

  • 7. [Multidisciplinary treatment of malignant melanoma of the nose and paranasal sinuses--with special reference to oral administration of enterosoluble BCG capsules].
    Saito H, Hozawa J, Takagi A, Fukuoka K, Nozawa I, Kamimura T.
    Gan To Kagaku Ryoho; 1982 Sep 28; 9(9):1555-61. PubMed ID: 6191718
    [Abstract] [Full Text] [Related]

  • 8. Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery.
    Zbar B, Canti G, Ashley MP, Rapp HJ, Hunter JT, Ribi E.
    Cancer Res; 1979 May 28; 39(5):1597-603. PubMed ID: 427799
    [No Abstract] [Full Text] [Related]

  • 9. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
    Schlag PM.
    Oncologist; 1998 May 28; 3(5):VI-VII. PubMed ID: 10388128
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms].
    Grigorovich NA, Risina DIa, Nodel'son SE.
    Vopr Onkol; 1984 May 28; 30(7):102-6. PubMed ID: 6464396
    [Abstract] [Full Text] [Related]

  • 11. Immunotherapy of malignancies: current status.
    Eilber FR, Holmes EC, Morton DL, Ramming KP, Sparks FC.
    AJR Am J Roentgenol; 1976 May 28; 126(5):1088-93. PubMed ID: 178234
    [Abstract] [Full Text] [Related]

  • 12. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B, Ma J, Wang X, Su F, Li X, Yang S, Ma W, Zhang Y.
    Anat Rec (Hoboken); 2008 Oct 28; 291(10):1227-35. PubMed ID: 18561194
    [Abstract] [Full Text] [Related]

  • 13. [Intralymphatic treatment of lymph-node metastases with Lipiodol labeled with I-131, with special reference to malignant melanoma].
    Edwards JM.
    Minerva Med; 1967 Dec 12; 58(99):4512-3. PubMed ID: 4295505
    [No Abstract] [Full Text] [Related]

  • 14. Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.
    Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R.
    Melanoma Res; 2007 Dec 12; 17(6):393-9. PubMed ID: 17992123
    [Abstract] [Full Text] [Related]

  • 15. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
    Ishii K, Kurita-Taniguchi M, Aoki M, Kimura T, Kashiwazaki Y, Matsumoto M, Seya T.
    Immunol Lett; 2005 May 15; 98(2):280-90. PubMed ID: 15860229
    [Abstract] [Full Text] [Related]

  • 16. [Treatment of advanced primary lung cancer, particularly immunotherapy with BCG-CWS (author's transl)].
    Ohta M, Iida A, Ueda H, Yasumoto K, Manabe H.
    Kyobu Geka; 1977 Jul 15; 30(7):581-5. PubMed ID: 904107
    [No Abstract] [Full Text] [Related]

  • 17. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
    Udagawa M, Kudo-Saito C, Hasegawa G, Yano K, Yamamoto A, Yaguchi M, Toda M, Azuma I, Iwai T, Kawakami Y.
    Clin Cancer Res; 2006 Dec 15; 12(24):7465-75. PubMed ID: 17189420
    [Abstract] [Full Text] [Related]

  • 18. Long-term effects of bacille Calmette-Guérin perfusion therapy for treatment of transitional cell carcinoma in situ of upper urinary tract.
    Hayashida Y, Nomata K, Noguchi M, Eguchi J, Koga S, Yamashita S, Hayashi M, Kanatake H.
    Urology; 2004 Jun 15; 63(6):1084-8. PubMed ID: 15183955
    [Abstract] [Full Text] [Related]

  • 19. Intralymphatic BCG in the treatment of gynecologic malignancies: a phase I study.
    Mangan C, Jeglum KA, Sedlacek TV, Giuntoli RL, Wheeler JE, Rubin E, Mikuta JJ.
    Cancer; 1977 Dec 15; 40(6):2933-40. PubMed ID: 589560
    [Abstract] [Full Text] [Related]

  • 20. [Intralymphatic B.C.G. infusions. Preliminary results (40 cases)].
    Abbes M, Ayraud N, Schneider M, Cambon P.
    Nouv Presse Med; 1976 Oct 23; 5(35):2303-6. PubMed ID: 135968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.